Driptan

Roman name

Driptane

The composition and the form of

1 tablet contains okshibutinina hydrochloride 5 mg; in a contour acheikova packing 30 pcs. , in a cardboard bundle one package.

Pharmacokinetics

C_max achieved through 45 minutes, T_1/2 is less than two hours (it increases in patients older).

Indications

Incontinence of urine caused by neuromuscular dysfunction of the bladder, including giperreflexia detruzora to spread EMG or spina bifida or idiopaticescoe incontinence.

Pregnancy and lactation

Perhaps only if the effect of therapy outweighs the potential risk to the fetus. At the time of treatment should stop breastfeeding.

Contraindications

Expressed by the outflow of urine from the bladder to the probable precipitation, intestinal occlusion, atony bowel heavy Ulcerative Colitis, expansion obodocna bowel, infants, glaucoma, children up to 5 years.

Patient interaction

Antiholinergicescoe to reinforce holinolitiki others.

Precautions

Prudence requires a weakened elderly patients, patients with circulatory dystonia, hernia ulcers holes diaphragm accompanied by reflux-ezofagitom, severe liver disease and Pocek.vo treatment may increase the symptoms of hyperthyroidism, ischemic heart disease, arrhythmia, chronic heart failure, prostate hyperplasia Jeleza.s use caution during the drivers of vehicles and people profession involve heightened concentration.

Dosing and Administration

Inside. Adults and 5 mg 2-3 times a day, patients older-to 5 mg twice a day. Children older than 5 years if there is a violation of the bladder neirogennogo nature to 5 mg twice a day, and night enuresis, 5 mg 2-3 times a day (the last dose should be taken at night).

Storage conditions

List B. At temperatures below 30 ° C

Shelf life

3 years

The registration

014671/01-2002

Directory → Wegetotropona funds → Holinoliticaskie funds → M-holinolitiki → Driptan